- GlobeNewswire•22 days agoERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT
MIAMI, Sept. 30, 2016-- ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, previously disclosed that the Company expected the NYSE MKT LLC to initiate procedures to delist the Company’ ...
- GlobeNewswire•23 days agoERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards
MIAMI, Sept. 29, 2016-- As previously reported, ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, implemented during the third quarter of 2015, among other things, a new, enhanced ...
- GlobeNewswire•2 months ago
MIAMI, Aug. 26, 2016-- ERBA Diagnostics, Inc., a fully integrated in vitro diagnostics company, announced today that, on August 23, 2016, the Company received a letter from NYSE MKT LLC stating that the ...
ERBA Diagnostics, Inc. (ERB)
NYSE MKT - NYSE MKT Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-12.50|
|Avg Vol (3m)||28,701|
|Dividend & Yield||N/A (N/A)|